Company intelligence / Profile preview

Mobius Scientific

Washington, District of Columbia, United Statesmobius-scientific.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Mobius Scientific is developing a novel biologic platform aimed at treating the root causes of chronic diseases, starting with retinal health and age-related macular degeneration. The company’s approach targets underlying lipid accumulation, which is implicated in both eye disease and broader chronic conditions. Early results from founder Dr. Nehal Mehta’s prior work suggest promise in improving vascular inflammation through similar therapeutic strategies, but no published clinical trial outcomes for Mobius programs are available yet.[1][2][3][5]

Therapeutic areas
CardiovascularOphthalmology
Modalities
Biologics (targeted biologic therapies)Nanodisc technology[4]
Industry
Biotech
02

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of latest information.[5] The company has received support from regional biohealth organizations.

Beyond the preview

Go deeper on Mobius Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mobius Scientific.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call